Skip to main content
Log in

Diagnostic value of transbronchial lung biopsy in peripheral lung cancer

  • Published:
The Chinese-German Journal of Clinical Oncology

Abstract

Objective

The purpose of this study was to evaluate the diagnostic value of transbronchial lung biopsy (TBLB) in peripheral lung cancer.

Methods

78 cases of peripheral lung cancer which could not be observed by bronchoscope were selected from the Second Affiliated Hospital of Sun Yat-sen University (China), of which 42 cases were diagnosed by TBLB. Among the 36 cases of peripheral lung cancer that could not be able to be diagnosed by TBLB, 22 cases were diagnosed by percutaneous lung biopsy (PNLB) and 14 cases being left were diagnosed by surgical specimens biopsy, lymphadenopathy biopsy, pleural biopsy or pleural effusion cytology.

Results

The positive rates produced by TBLB and transbronchial brush biopsy were 53.8% and 8.9%, respectively, and the combined positive rate was 57.7%. The positive rate produced by TBLB was higher than that of transbronchial brush biopsy (P < 0.01). As the tumor’s diameter increased, the positive rate of the biopsy was higher (P < 0.05). The positive rate of biopsy of the right lung was not significantly higher than that of the left lung (P > 0.05). The positive rate of biopsy of the inferior lobes was not significantly higher than that of the upper lobes of the lung (P > 0.05). The lesions of the tumors which were nearer to the infield and hilar of the lung got a higher positive rate (P < 0.01). The incidence of complications in PNLB was much higher than that in TBLB (P < 0.05).

Conclusion

TBLB is an important method in the diagnosis of peripheral lung cancer. Combination of TBLB and other methods can increase the positive rate in the diagnosis of peripheral lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. The bronchoscope group of anapneapathology branch of Chinese medical association. The guide for diagnostic abnormal curvature bronchoscope (2008 edition). Chin J Tuberc Respir Dis (Chinese), 2008, 31: 14–17.

    Google Scholar 

  2. Cappuzzo F, Bartolini S, Crinò L. Emerging drugs for non-small cell lung cancer. Expert Opin Emerg Drugs, 2003, 8: 179–192.

    Article  CAS  PubMed  Google Scholar 

  3. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol, 2002, 13: 1087–1093.

    Article  CAS  PubMed  Google Scholar 

  4. Lu ZY, Zhong NS, ed. Internal medicine. 7th ed. Beijing: The People Health Publication, 2008. 124.

    Google Scholar 

  5. Kawaraya M, Gemba K, Ueoka H, et al. Evaluation of various cytological examinations by bronchoscopy in the diagnosis of peripheral lung cancer. Br J Cancer, 2003, 89: 1885–1888.

    Article  CAS  PubMed  Google Scholar 

  6. Liu CT, Zhang JC, ed. The contemporary diagnostics and therapeutics via bronchofibroscope. 3th ed. Beijing: The People Military Surgeon Publishing, 2005. 62–63.

    Google Scholar 

  7. Wen SN, Wu XH, Ying KJ, et al. To diagnosis bellows tumor via percutaneous needle lung biopsy: the comparison for the two amining methods of ultrasound and CT. Chin J Tuberc Respir Dis (Chinese), 2004, 27: 571–572.

    Google Scholar 

  8. Chao RB, He LH, He XZ. The value of diagnosing the peripheral type of lung pathological changes by examining the vital capacity with electron bronchus lens. J Clin Pulmon Med (Chinese), 2005, 10: 762–763.

    Google Scholar 

  9. Pu XS. The censorship and analysis for the bronchofibroscope and lung cancer clinical feature. Chin Healthc Innov (Chinese), 2007, 2:68.

    Google Scholar 

  10. Yeow KM, Su IH, Pan KT, et al. Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies. Chest, 2004, 126: 748–754.

    Article  PubMed  Google Scholar 

  11. Cox JE, Chiles C, McManus CM, et al. Transthoracic needle aspiration biopsy: variables that affect risk of pneumothorax. Radiology, 1999, 212: 165–168.

    CAS  PubMed  Google Scholar 

  12. García-Río F, Pino JM, Casadevall J, et al. Use of spirometry to predict risk of pneumothorax in CT-guided needle biopsy of the lung. J Comput Assist Tomogr, 1996, 20: 20–23.

    Article  PubMed  Google Scholar 

  13. Cai S, Chen P. Diagnosis of 101 cases of unknown lung mass. J Chin Physic (Chinese), 2005, 7: 612–614.

    Google Scholar 

  14. Liu FS, ed. The classification of Chinese oncopathology. 1st ed. Beijing: Science and Technology Literature Publishing, 2001. 107–112.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jianguo Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, J., Tang, W., Wen, B. et al. Diagnostic value of transbronchial lung biopsy in peripheral lung cancer. Chin. -Ger. J. Clin. Oncol. 8, 592–595 (2009). https://doi.org/10.1007/s10330-009-0119-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-009-0119-2

Key words

Navigation